This Stock is one of the most inexpensive in the Biotech Sector . They have $45.7 M in Cash and a Market Cap of just $67 M that's ridiculous for a Company with such a Mega Pipeline .Another good sign is that Management bought 187k Shares in the last few weeks .This is the Perfect time to load up before the speculators jumping in.
